Publications:

Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.

Frontiers In Immunology

Li, Na N; Wang, Jiahong J; Zhan, Xianquan X

Publication Date: 2021

Variant appearance in text: POLE: 1216G>A

PubMed Link: 34887858

Variant Present in the following documents:

• Table_3.xlsx, sheet 1

View BVdb publication page

Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor.

Annals Of Translational Medicine

He, Junjun J; Ouyang, Wei W; Zhao, Wugan W; Shao, Lin L; Li, Bing B; Liu, Bihao B; Wang, Dejuan D; Han-Zhang, Han H; Zhang, Zhou Z; Shao, Liang L; Li, Wencai W

Publication Date: 2021-01

Variant appearance in text: POLE: D406N

PubMed Link: 33569431

Variant Present in the following documents:

• Main text
• atm-09-02-129.pdf

View BVdb publication page

Heterogeneous responses and resistant mechanisms to crizotinib in ALK-positive advanced non-small cell lung cancer.

Thoracic Cancer

Kang, Jin J; Chen, Hua-Jun HJ; Zhang, Xu-Chao XC; Su, Jian J; Zhou, Qing Q; Tu, Hai-Yan HY; Wang, Zhen Z; Wang, Bin-Chao BC; Zhong, Wen-Zhao WZ; Yang, Xue-Ning XN; Chen, Zhi-Hong ZH; Ding, Yan Y; Wu, Xue X; Wang, Mei M; Fu, Jian-Gang JG; Yang, Zhenfan Z; Zhang, Xian X; Shao, Yang W YW; Wu, Yi-Long YL; Yang, Jin-Ji JJ

Publication Date: 2018-09

Variant appearance in text: POLE: D406N

PubMed Link: 29978950

Variant Present in the following documents:

• TCA-9-1093-s006.xlsx, sheet 1

View BVdb publication page